Lam_2012_Bioorg.Med.Chem.Lett_22_6628

Reference

Title : Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors - Lam_2012_Bioorg.Med.Chem.Lett_22_6628
Author(s) : Lam B , Zhang Z , Stafford JA , Skene RJ , Shi L , Gwaltney SL, 2nd
Ref : Bioorganic & Medicinal Chemistry Lett , 22 :6628 , 2012
Abstract :

Dipeptidyl peptidase IV (DPP-4) inhibitors have been shown to enhance GLP-1 levels and thereby improve hyperglycemia in type II diabetes. From a small fragment hit, using structure-based design, we have discovered a new class of non-covalent, potent and selective DPP-4 inhibitors.

PubMedSearch : Lam_2012_Bioorg.Med.Chem.Lett_22_6628
PubMedID: 23025999
Gene_locus related to this paper: human-DPP4

Related information

Inhibitor CHEMBL2159182
Gene_locus human-DPP4
Structure 4G1F

Citations formats

Lam B, Zhang Z, Stafford JA, Skene RJ, Shi L, Gwaltney SL, 2nd (2012)
Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors
Bioorganic & Medicinal Chemistry Lett 22 :6628

Lam B, Zhang Z, Stafford JA, Skene RJ, Shi L, Gwaltney SL, 2nd (2012)
Bioorganic & Medicinal Chemistry Lett 22 :6628